Asuragen and Life Technologies Launch Leukemia Test in Europe
Asuragen Inc and Life Technologies Corp announced today that they have achieved CE-marking and commercial launch in Europe of the BCR/ABL1 Quant Test.
Read MoreSearch Results for: leukemia
Protein Predicts Leukemia Prognosis, May be Therapeutic Target
Posted by Clinical Lab Products | Jul 9, 2010 | Cancer, Miscellaneous |
Researchers at Whitehead Institute and Childrens Hospital Boston have identified a protein, called Musashi 2, that is predictive of prognosis in acute myeloid leukemia (AML) and chronic myeloid leukemia (CML) patients.
Read MoreBiomerica Purchases Technology and Manufacturing Rights for New TPMT Test
Posted by Clinical Lab Products | Jun 9, 2010 | Miscellaneous |
Biomerica Inc announced that it has purchased a patented technology and the manufacturing rights for a new Thiopurine methyltransferase (TPMT) test to detect patients who are at risk of developing severe side effects.
Read MoreQIAGEN Drives The Development Of Companion Diagnostics With Two Key Appointments
Posted by Clinical Lab Products | Apr 22, 2010 | Cancer, Miscellaneous |
QIAGEN has announced the appointment of two high level members, Dr Pia Garguilo and Richard Watts, to the recently formed Pharma Business Development team.
Read MorePerkinElmer Enters Into Agreement to Acquire Signature Genomic Laboratories
Posted by Clinical Lab Products | Apr 16, 2010 | Cancer, Miscellaneous |
PerkinElmer Inc has announced that it has entered into a definitive agreement to acquire Signature Genomic Laboratories LLC, a diagnostic genetic testing company based in Spokane, Wash.
Read More